5-MeO-DiPT

Structural formula
General
Surname	5-MeO-DiPT
other names	5-methoxy- N , N -diisopropyltryptamine; Diisopropyl [2- (5-methoxyindol-3-yl) ethyl] azane ( IUPAC );
Molecular formula	C 17 H 26 N 2 O
External identifiers / databases
PubChem	151182
ChemSpider	133247
DrugBank	DB01441
Wikidata	Q2983762
properties
Molar mass	274.4 g mol −1
safety instructions
GHS hazard labeling ; no classification available
GHS hazard labeling ; no classification available
	As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

5-Methoxy- N , N -diisopropyltryptamine (5-MeO-DiPT or 5-MeO-DIPT for short; also Foxy) is a chemical compound from the tryptamine family .

5-MeO-DiPT was first synthesized by Alexander Shulgin . It is an analog of 5-MeO-DMT and 5-MeO-AMT .

effect

5-MeO-DiPT is a lesser-known psychedelic drug that works analogously to other tryptamines and classic hallucinogens via the 5-HT _2A receptor . It acts as a SERT inhibitor and binds to the receptors 5-HT1A, 5-HT2A and 5-HT2C. 5-MeO-DiPT is neurotoxic in rats.

5-MeO-DiPT is usually taken orally, rarely nasally. The hallucinogenic effects are similar to those of psilocin . As with all hallucinogens, however, there is a risk of triggering a latent psychosis or the development of drug psychosis .

Legal status

5-MeO-DIPT is subject to the Narcotics Act in Germany . It is a non- marketable narcotic.

In Sweden , 5-MeO-DiPT (together with 5-AcO-DET, 5-HO-DET, 5-AcO-MiPT and bk-MDMA) has been a hazardous substance since November 1, 2005, which does not allow medical use.

literature

SL Hill, SH Thomas: Clinical toxicology of newer recreational drugs. In: Clinical toxicology. Volume 49, Number 8, October 2011, pp. 705-719, doi : 10.3109 / 15563650.2011.615318 , PMID 21970769 .

Individual evidence

↑ ^a ^b ^c Law on the traffic in narcotics (Narcotics Act - BtMG) - Annex I (to Section 1, Paragraph 1) - (narcotics that are not marketable). In: Federal Law Gazette. Accessed on January 28, 2018 .
↑ This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.
↑ C. Sogawa, N. Sogawa, J. Tagawa, A. Fujino, K. Ohyama, M. Asanuma, M. Funada, S. Kitayama: 5-Methoxy-N, N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter. In: Toxicology Letters . Volume 170, number 1, 2007, pp. 75-82, doi : 10.1016 / j.toxlet.2007.02.007 , PMID 17382495 .
↑ AM Araújo, F. Carvalho, M. d. Bastos, P. Guedes de Pinho, M. Carvalho: The hallucinogenic world of tryptamines: an updated review. In: Archives of toxicology. Volume 89, Number 8, August 2015, pp. 1151–1173, doi : 10.1007 / s00204-015-1513-x , PMID 25877327 .
↑ ^a ^b K. Noworyta-Sokołowska, K. Kamińska, G. Kreiner, Z. Rogóż, K. Gołembiowska: Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive tryptamines Derivative in Rats. In: Neurotoxicity research. Volume 30, Number 4, November 2016, pp. 606-619, doi : 10.1007 / s12640-016-9654-0 , PMID 27461536 , PMC 5047954 (free full text).

[Anlage1-1] Law on the traffic in narcotics (Narcotics Act - BtMG) - Annex I (to Section 1, Paragraph 1) - (narcotics that are not marketable). In: Federal Law Gazette. Accessed on January 28, 2018 .

[NV-2] This substance has either not yet been classified with regard to its hazardousness or a reliable and citable source has not yet been found.

[3] C. Sogawa, N. Sogawa, J. Tagawa, A. Fujino, K. Ohyama, M. Asanuma, M. Funada, S. Kitayama: 5-Methoxy-N, N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter. In: Toxicology Letters . Volume 170, number 1, 2007, pp. 75-82, doi : 10.1016 / j.toxlet.2007.02.007 , PMID 17382495 .

[4] AM Araújo, F. Carvalho, M. d. Bastos, P. Guedes de Pinho, M. Carvalho: The hallucinogenic world of tryptamines: an updated review. In: Archives of toxicology. Volume 89, Number 8, August 2015, pp. 1151–1173, doi : 10.1007 / s00204-015-1513-x , PMID 25877327 .

[Noworyta-Sokołowska-5] K. Noworyta-Sokołowska, K. Kamińska, G. Kreiner, Z. Rogóż, K. Gołembiowska: Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive tryptamines Derivative in Rats. In: Neurotoxicity research. Volume 30, Number 4, November 2016, pp. 606-619, doi : 10.1007 / s12640-016-9654-0 , PMID 27461536 , PMC 5047954 (free full text).